COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 2182: Articles 21811-21820  | Next

Evaluating the Sensitivity of SARS-CoV-2 Infection Rates on College Campuses to Wastewater Surveillance
Wong, T. E., Thurston, G. M., Barlow, N., Cahill, N., Carichino, L., Maki, K., Ross, D., Schneider, J.
10.1101/2020.10.09.20210245 — Posted: 2020-10-11
Polyester Nasal Swabs Collected in a Dry Tube are a Robust and Inexpensive, Minimal Self-Collection Kit for SARS-CoV-2 Testing
Rains, J. D., Padgett, L. R., Ahls, C. L., Samarasinghe, D. K., Wallander, M. L., Kennington, L. A., Tu, Y.-P., Elliott, J. S.
10.1101/2020.10.09.20210302 — Posted: 2020-10-11
Enoxaparin is associated with lower rates of thrombosis, kidney injury, and mortality than Unfractionated Heparin in hospitalized COVID patients
Pawlowski, C., Venkatakrishnan, A., Kirkup, C., Berner, G., Puranik, A., O'Horo, J. C., Badley, A. D., Soundararajan, V.
10.1101/2020.10.06.20208025 — Posted: 2020-10-11
Low zinc levels at clinical admission associates with poor outcomes in COVID-19
Vogel, M., Tallo-Parra, M., Herrera-Fernandez, V., Perez-Vilaro, G., Chillon, M., Nogues, X., Gomez-Zorrilla, S., Lopez-Montesinos, I., Villar, J., Sorli-Redo, M. L., Horcajada, J. P., Garcia-Giralt, N., Pascual, J., Diez, J., Vicente, R., Guerri-Fernandez, R.
10.1101/2020.10.07.20208645 — Posted: 2020-10-11 Discussion: Onsite | Offsite
Factors associated with progression to critical illness in 28 days among COVID-19 patients: results from a tertiary care hospital in Istanbul, Turkey
Sili, U., Ay, P., Topuzoglu, A., Bilgin, H., Tukenmez Tigen, E., Erturk Sengel, B., Yagci Caglayik, D., Balcan, B., Kocakaya, D., Olgun Yildizeli, S., Gul, F., Bilgili, B., Can Sarinoglu, R., Karahasan Yagci, A., Mulazimoglu Durmusoglu, L., Eryuksel, E., Odabasi, Z., Direskeneli, H., Karakurt, S., Cinel, I., Korten, V.
10.1101/2020.10.09.20209775 — Posted: 2020-10-11
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay
Elizondo, V., Harkins, G. W., Mabvakure, B., Smidt, S., Zappile, P., Marier, C., Maurano, M. T., Perez, V., Mazza, N., Beloso, C., Ifran, S., Fernandez, M., Santini, A., Perez, V., Estevez, V., Nin, M., Manrique, G., Perez, L., Ross, F., Boschi, S., Zubillaga, M. N., Balleste, R., Dellicour, S., Heguy, A., Duerr, R.
10.1101/2020.10.08.20208546 — Posted: 2020-10-11
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics
Mason, C. Y., Kanitkar, T., Richardson, C. J., Lanzman, M., Stone, Z., Mahungu, T., Mack, D., Wey, E. Q., Lamb, L., Balakrishnan, I., Pollara, G.
10.1101/2020.10.09.20199778 — Posted: 2020-10-11
Age-targeted dose allocation can halve COVID-19 vaccine requirements
Meehan, M. T., Cocks, D. G., Caldwell, J. M., Trauer, J. M., Adekunle, A. I., Ragonnet, R. R., McBryde, E. S.
10.1101/2020.10.08.20208108 — Posted: 2020-10-11
Extended laboratory panel testing in the Emergency Department for risk-stratification of patients with COVID-19: a single centre retrospective service evaluation
Ponsford, M. J., Burton, R. J., Smith, L., Khan, P., Andrews, R., Cuff, S., Tan, L., Eberl, M., Humphreys, I. R., Babolhavaeji, F., Artemiou, A., Pandey, M., Jolles, S., Underwood, J.
10.1101/2020.10.06.20205369 — Posted: 2020-10-11
Risk of death during the 2020 UK COVID-19 epidemic among people with rare autoimmune diseases compared to the general population. Preliminary results from the RECORDER project.
Peach, E. J., Rutter, M., Lanyon, P. C., Grainge, M. J., Hubbard, R. B., Aston, J., Bythell, M., Stevens, S., Pearce, F. A.
10.1101/2020.10.09.20210237 — Posted: 2020-10-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).